EUVIMEDEUVIMED entdecken
Crossref

Thrombin generation on vascular cells in the presence of factor VIII and/or emicizumab

Sénadé Atsou, Célia Schellenberg, Jeremy Lagrange, Patrick Lacolley, Peter J Lenting, Cécile V Denis, Olivier D Christophe, Véronique Regnault

Journal of Thrombosis and Haemostasis · 2024

DOI: 10.1016/j.jtha.2023.09.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2024. Verfasst von Sénadé Atsou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris-Saclay, INSERM, Hémostase Inflammation Thrombose HITh U1176, 94276, Le KremLin-Bicêtre, France. Hauptthemen laut MEDLINE: Hemostatics, Antibodies, Bispecific, Hemophilia A. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The effect of factor VIII (FVIII) or emicizumab on thrombin generation is usually assessed in assays using synthetic phospholipids. Here, we assessed thrombin generation at the surface of human arterial cells (aortic endothelial cells [hAECs] and aortic vascular smooth muscle cells [hVSMCs]). OBJECTIVES: To explore the capacity of hAECs (resting or stimulated) and hVSMCs to support thrombin generation by FVIII or emicizumab. METHODS: Primary hVSMCs and hAECs were analyzed for tissue factor (TF)-activity and antigen, phosphatidylserine (PS)-exposure, tissue factor pathway inhibitor (TFPI)-content and thrombomodulin expression. Cells were incubated with FVIII-deficient plasma spiked with FVIII, emicizumab, activated prothrombin complex concentrate (APCC) or combinations thereof. RESULTS: TF activity and PS-exposure were present on both hVSMCs and hAECs. In contrast, thrombomodulin and TFPI were expressed on hAECs, while virtually lacking on hVSMCs, confirming the procoagulant nature of hVSMCs. Tumor necrosis factor α-mediated stimulation of hAECs increased not only TF antigen, TF activity, and PS-exposure but also TFPI and thrombomodulin expression. As expected, FVIII and emicizumab promoted thrombin generation on nonstimulated hAECs and hVSMCs, with more thrombin being generated on hVSMCs. Unexpectedly, FVIII and emicizumab increased thrombin generation to a lesser extent on stimulated hAECs compared with nonstimulated hAECs. Finally, adding emicizumab to FVIII did not further increase thrombin generation, whereas the addition of emicizumab to APCC resulted in exaggerated thrombin generation. CONCLUSION: Tumor necrosis factor stimulation of hAECs increases both pro- and anticoagulant activity. Unexpectedly, the increased anticoagulant activity is sufficient to limit both FVIII- and emicizumab-induced thrombin generation. This protective effect disappears when emicizumab is combined with APCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemostaticsAntibodies, BispecificHemophilia AHumansFactor VIIIThrombinThrombomodulinEndothelial CellsFactor VIIaFactor IXAnticoagulantsAntibodies, Monoclonal, Humanized

Stichwörter der Autor:innen

emicizumabendothelial cellsfactor VIIIsmooth muscle cellsthrombin generation

Substanzen

Factor VIIIThrombinThrombomodulinHemostaticsAntibodies, BispecificFactor VIIaFactor IXAnticoagulantsemicizumabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Université Paris-Saclay, INSERM, Hémostase Inflammation Thrombose HITh U1176, 94276, Le KremLin-Bicêtre, France.
  • Université de Lorraine, INSERM, Défaillance Cardiovasculaire Aigüe et Chronique DCAC U1116, 54505 Vandoeuvre-les-Nancy, France.
  • Université Paris-Saclay, INSERM, Hémostase Inflammation Thrombose HITh U1176, 94276, Le KremLin-Bicêtre, France. Electronic address: peter.lenting@inserm.fr.
  • Université Paris-Saclay, INSERM, Hémostase Inflammation Thrombose HITh U1176, 94276, Le KremLin-Bicêtre, France. Electronic address: https://twitter.com/InsermU1176.

Zitieren

APA

Atsou, S., Schellenberg, C., Lagrange, J., Lacolley, P., Lenting, P. J., Denis, C. V., Christophe, O. D., & Regnault, V. (2024). Thrombin generation on vascular cells in the presence of factor VIII and/or emicizumab. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2023.09.017

Vancouver

Atsou S, Schellenberg C, Lagrange J, Lacolley P, Lenting PJ, Denis CV, et al. Thrombin generation on vascular cells in the presence of factor VIII and/or emicizumab. Journal of Thrombosis and Haemostasis. 2024. doi:10.1016/j.jtha.2023.09.017

BibTeX
@article{Atsou2024,
  author = {Atsou, Sénadé and Schellenberg, Célia and Lagrange, Jeremy and Lacolley, Patrick and Lenting, Peter J and Denis, Cécile V and Christophe, Olivier D and Regnault, Véronique},
  title = {Thrombin generation on vascular cells in the presence of factor VIII and/or emicizumab},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2024},
  doi = {10.1016/j.jtha.2023.09.017}
}
Kostenlos starten →